Skip to main content
SpringerLink
Log in

Introduction to Molecular Diagnostic Testing in Dermatology and Dermatopathology

  • Chapter
  • First Online:
Molecular Diagnostics in Dermatology and Dermatopathology

Part of the book series: Current Clinical Pathology ((CCPATH))

Abstract

The complete sequencing of the human genome has ushered in an era of medical advances that was previously unimaginable. Scientists are continually discovering novel genetic and epigenetic mechanisms that are associated with human disease states and therapeutic responses. The ability to determine the underlying defect(s) in single-gene (Mendelian) diseases, many of which are rare, has improved both diagnosis in symptomatic patients and risk prediction of future disease in asymptomatic individuals. Potential applications of genomic discoveries include: (1) development of carrier, screening and diagnostic tests for single-gene disorders; (2) evaluation of several genetic loci in an effort to construct disease susceptibility profiles for non-Mendelian diseases, based on multiple gene and/or gene–environment relationships; and (3) pharmacogenomic testing to predict drug–genome interactions [1]. It has been estimated that ∼5% of the ∼25,000 genes in the human genome are of diagnostic significance; therefore, the potential exists to develop ∼1,500 gene-based tests [2]. With regard to dermatologic conditions, exciting research is emerging and new applications are now being incorporated into clinical practice. Molecular diagnostic tests are transforming laboratory medicine and patient care, and becoming indispensable for physicians involved in the management of skin diseases, including dermatologists and dermatopathologists. Nucleic acid-based testing is becoming a crucial diagnostic tool, not only in the setting of inherited disorders (i.e., genodermatoses), but also for a wide variety of cutaneous solid and hematopoietic tumors, inflammatory dermatoses, and infectious conditions. In view of the increasing numbers of molecular diagnostic articles published in the dermatology literature, and potential application of these methodologies in clinical practice, a basic knowledge of the principles of molecular diagnostics is now essential for the physician who specializes in the diagnosis and/or treatment of skin diseases. Figure 1.1 illustrates the integration of research and diagnostic strategies in the study of skin diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grosse SD, Khoury MJ. What is the clinical utility of genetic testing? Genet Med. 2006;8:448–50.

    Article  PubMed  Google Scholar 

  2. Business Strategies for Molecular Diagnostics in the Lab. In: Murg S, Terry M, editors. Including state of the market report, 2nd ed. Newark: Washington G-2 Reports; 2009.

    Google Scholar 

  3. Dudda-Subramanya R, Alexis AF, Siu K, et al. Alopecia areata: genetic complexity underlies clinical heterogeneity. Eur J Dermatol. 2007;17:367–74.

    Google Scholar 

  4. GeneTests. http://www.genetests.org/ (2010). Accessed 2 Sept 2010.

  5. Kesselheim AS, Mello MM. Gene patenting – is the pendulum swinging back? N Engl J Med. 2010;362:1855–8.

    Article  PubMed  CAS  Google Scholar 

  6. Association for Molecular Pathology. http://www.amp.org/ (2010). Accessed 2 Sept 2010.

  7. Pene F, Courtine E, Cariou A, et al. Toward theragnostics. Crit Care Med. 2009;37(1 Suppl):S50–8.

    Article  PubMed  CAS  Google Scholar 

  8. Holtzman NA, Watson MS. Promoting safe and effective genetic testing in the United States. Final report of the task force on genetic testing. http://www.genome.gov/10001733. Accessed 2 Sept 2010.

  9. Netto GJ, Saad RD. Diagnostic molecular pathology: an increasingly indispensable tool for the practicing pathologist. Arch Pathol Lab Med. 2006;130:1339–48.

    PubMed  CAS  Google Scholar 

  10. Chen B, Gagnon M, Shahangian S, et al. Good laboratory practices for molecular genetic testing for heritable diseases and conditions. Morbidity Mortality Weekly Reports. 2009;58:1–29.

    Google Scholar 

  11. Leachman SA, Carucci J, Kohlmann W, et al. Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol. 2009;61:677.e1–14.

    Article  Google Scholar 

  12. GenoMEL, the Melanoma Genetics Consortium. http://www.genomel.org/ (2010). Accessed 2 Sept 2010.

  13. Genesis Genomics. http://www.genesisgenomics.com/ (2010). Accessed 2 Sept 2010.

  14. Melanoma Diagnostics, Inc. http://www.melanomadiagnostics.com/ (2010). Accessed 2 Sept 2010.

  15. Kashani-Sabet M, Rangel J, Torabian S, et al. A multi-marker assay to distinguish malignant melanomas from benign nevi. Proc Natl Acad Sci USA. 2009;106:6268–72.

    Article  PubMed  CAS  Google Scholar 

  16. Kashani-Sabet M, Venna S, Nosrati M, et al. A multimarker prognostic assay for primary cutaneous melanoma. Clin Cancer Res. 2009;15:6987–92.

    Article  PubMed  CAS  Google Scholar 

  17. DermTech International. http://dermtech.com/ (2010). Accessed 2 Sept 2010.

  18. NeoGenomics Laboratories. http://www.neogenomics.org/ (2010). Accessed 2 Sept 2010.

  19. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135–47.

    Article  PubMed  CAS  Google Scholar 

  20. Bauer J, Bastian BC. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther. 2006;19:40–9.

    Article  PubMed  Google Scholar 

  21. Gerami P, Jewell SS, Morrison LE, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol. 2009;33:1146–56.

    Article  PubMed  Google Scholar 

  22. Wong R, Tran V, Talwalker S, et al. Analysis of RNA recovery and gene expression in the epidermis using non-invasive tape stripping. J Dermatol Sci. 2006;44:81–92.

    Article  PubMed  CAS  Google Scholar 

  23. Benson NR, Papenfuss J, Wong R, et al. An analysis of select pathogenic messages in lesional and non-lesional psoriatic skin using non-invasive tape harvesting. J Invest Dermatol. 2006;126:2234–41.

    Article  PubMed  CAS  Google Scholar 

  24. Morhenn VB, Chang EY, Rheins LA. A noninvasive method for quantifying and distinguishing inflammatory skin reactions. J Am Acad Dermatol. 1999;41:687–92.

    Article  PubMed  CAS  Google Scholar 

  25. Wong R, Tran V, Morhenn V, et al. Use of RT-PCR and DNA microarrays to characterize RNA recovered by non-invasive tape harvesting of normal and inflamed skin. J Invest Dermatol. 2004;123:159–67.

    Article  PubMed  CAS  Google Scholar 

  26. DermaGenoma. http://www.dermagenoma.com/ (2010). Accessed 2 Sept 2010.

  27. Bender RA, Erlander MG. Molecular classification of unknown primary cancer. Semin Oncol. 2009;36:38–43.

    Article  PubMed  CAS  Google Scholar 

  28. Pincelli C, Pignatti M, Borroni RG. Pharmacogenomics in dermatology: from susceptibility genes to personalized therapy. Exp Dermatol. 2009;18:337–49.

    Article  PubMed  CAS  Google Scholar 

  29. Bowers J. DNA goes DTC. Genetic testing firms bring personal genomics to the consumer. Dermatol World. 2009;19:22.

    Google Scholar 

  30. Human Genetics Commission. http://www.hgc.gov.uk/Client/index.asp?ContentId=1 (2010). Accessed 2 Sept 2010.

  31. Levy H. Genetic testing goes commercial. Skin & Allergy News. 2009;40:12.

    Google Scholar 

  32. SNPedia. http://www.snpedia.com/. Accessed 6 May 2010.

Download references

Author information

Authors and Affiliations

  1. Division of Dermatopathology, Department of Dermatology, University of Connecticut Health Center, 21 South Rd., Farmington, CT, 06030, USA

    Michael J. Murphy

Authors
  1. Michael J. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. Murphy .

Editor information

Editors and Affiliations

  1. Health Center, Dept. Dermatology, University of Connecticut, Farmington Ave. 263, Farmington, 06030, Connecticut, USA

    Michael J. Murphy

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Murphy, M.J. (2011). Introduction to Molecular Diagnostic Testing in Dermatology and Dermatopathology. In: Murphy, M. (eds) Molecular Diagnostics in Dermatology and Dermatopathology. Current Clinical Pathology. Humana Press. https://doi.org/10.1007/978-1-60761-171-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-171-4_1

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-170-7

  • Online ISBN: 978-1-60761-171-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation